Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Tolerability of Fluval AB Novo in Children and Adolescents
NCT02387294Phase 3Completed
- Sponsor
- Fluart Innovative Vaccines
- Start
- Oct 2014
- Primary completion
- Dec 2014
- Modality
- Prophylactic Vaccines
01
Overview
A Phase 3 trial of Fluval AB Novo in influenza, sponsored by Fluart Innovative Vaccines. Started Oct 2014; status: completed.
02
Drugs
Fluval AB Novo
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02387294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02387294.